
IMWG Conference Series: ASH 2019 Orlando, FL
ASH 2019
Patients, caregivers, and doctors around the world can view the IMF's popular livestream IMWG Conference Series, "Making Sense of Treatment" from Orlando, FL. IMF Chairman Dr. Brian G.M. Durie, Dr. Maria V. Mateos, and IMF Chief Medical Officer Dr. Joseph Mikhael distill, debate, and discuss the latest news and trends in the treatment of multiple myeloma from the 61st Annual ASH Meeting.
Download Slides
Topics include:
- Smoldering Myeloma
- Frontline Therapy
- Significance of FiSH testing
- CAR T therapy/Bi-specific T Cell engagers/MoAb
- Novel agents/combinations
with an educational grant from:
Amgen Oncology, Celgene, Takeda Oncology, Janssen Oncology
Previous Post
Diagnosis and Risk Stratification of Plasma Cell Disorders: To Treat or Not to Treat
Next Post
B-Cell Maturation Antigen (BCMA) 2+1 T-Cell Engager CC-93269 in Patients with Relapsed Refractory Multiple Myeloma